2027 Unit information is now available. View 2027 unit information
Cradle Coast, Hobart, Launceston
Introduction
Therapeutics in Practice 4 is designed to further develop your ability to determine the most appropriate pharmacotherapeutic management for a range of medical conditions. Drug therapy is the cornerstone for the management of most if not all common medical conditions. The unit builds on your understanding of pharmacology, human biology and basic therapeutics. Having covered a range of conditions in CSA322 and CSA306, you will address other common conditions (such as malignant disease) as well as look at overarching themes, such as geriatrics, paediatrics and gender-specific health issues. The knowledge gained in this unit will be fundamental to the hospital and community placements undertaken during the year. Therapeutics in Practice 4 will also form an important basis for further studies relating to Medication Reviews undertaken in Pharmacy Practice CSA416.
Summary
| Unit name | Therapeutics in Practice (4) |
| Unit code | CSA406 |
| Credit points | 12.5 |
| College/School | Health School of Pharmacy and Pharmacology |
| Discipline | Pharmacy |
| Coordinator | Mrs Kendall Stephens |
| Delivered By | University of Tasmania |
| Level | Honours |
Sustainable Development Goals
The Unit Coordinator has identified that this unit aligns with the following UN Sustainable Development Goals. We welcome your thoughts and feedback on the alignment of the unit with these goals.
Availability
| Location | Study period | Attendance options | Available to | ||
|---|---|---|---|---|---|
| Cradle Coast | Semester 1 |
|
|
|
|
| Hobart | Semester 1 |
|
|
|
|
| Launceston | Semester 1 |
|
|
|
|
- Key:
On-campus
Off-Campus
International students
Domestic students
Note
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
Key Dates
| Study Period | Start date | Census date | WW date | End date |
|---|---|---|---|---|
| Semester 1 | 22/2/2026 | 16/3/2026 | 19/4/2026 | 13/6/2026 |
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2026 are indicative and subject to change. Finalised census dates for 2026 will be available from the 1st October 2025. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
Learning Outcomes
- Evaluate medication-related problems.
- Develop patient-centred therapeutic plans that integrate clinical evidence, guidelines, policies and appropriate monitoring strategies to ensure safe and effective care.
- Communicate medication-related problems and pharmacotherapeutic recommendations.
Fee Information
| Field of Education | Commencing Student Contribution 1,3 | Grandfathered Student Contribution 1,3 | Approved Pathway Course Student Contribution 2,3 | Domestic Full Fee 4 |
|---|---|---|---|---|
| 019907 | $1,192.00 | $1,192.00 | not applicable | $2,862.00 |
- Available as a Commonwealth Supported Place
- HECS-HELP is available on this unit, depending on your eligibility3
- FEE-HELP is available on this unit, depending on your eligibility4
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UniConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
Requisites
Prerequisites
CSA306 and CSA357 and CSA321 and CSA326Co-requisites
CSA457 and CSA414Teaching
| Teaching Pattern | 3hr Independent learning weekly 1hr online seminar weekly 2hr on campus workshop weekly 3 hours simulated clinical rounds per fortnight 20min on campus mid HSP test - week 7 only |
|---|---|
| Assessment | Medication review and management plan (25%)|Mid-Semester oral examination (35%)|Oral examination (40%) |
| Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
| Required |
Required readings will be listed in the unit outline prior to the start of classes. |
|---|---|
| Recommended | It is recommended that you have the following textbook: DiPiro et al. Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical (12th Edition, ISBN 978-1-264-26454-4) In addition to the recommended textbook, students will be guided to a variety of other reading material relevant to the area of study. Links will be provided to these materials through MyLO where possible. The majority of these materials will be available online, either freely accessible or through the University Library. Students will also find the following resources (e-versions are available to pharmacy students via EPOCH) highly valuable for CSA406 and other units (e.g., CSA457, CSA430): - UpToDate, Wolters Kluwer |
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.